Angewandte Chemie International Edition · 2025 · 13 citations · 48 references
PharmacyOncologyPharmaceuticsChemotherapyDrug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanomedicineNucleic Acid DeliveryPhotothermal TherapyTargeted Cancer TherapyCancer NanotherapyCancer Photothermal TherapyHeat Shock Protein InhibitorsHydrophobic InsertionMolecular TargetingPhotothermal EffectsTargeted Photothermal TherapyTumor-targeted Drug Delivery
Albumin-based drug delivery system, exemplified by FDA-approved treatments like Abraxane, have demonstrated significant potential in cancer therapy. However, albumin carriers still suffer from poor tumor-targeting capability, leading to low efficacy and systemic side effects on healthy cells in applications. Here, we report a general method for modification of albumin drugs by aptamer coating shell that are hydrophobically inserted into the albumin surface, for constructing albumin drugs-cored spherical nucleic acid (adSNA). This adSNA platform allows for the versatile loading of various therapeutic agents, including chemotherapy drugs, polyphenols, cuproptosis inducers, and near-infrared (NIR) photosensitizers, enabling targeted tumor delivery. Compared with covalent method, the hydrophobic insertion method has been proven to be of greater simplicity, higher aptamer-grafting efficiency, superior tumor-targeting capabilities, and comparable stability under physiological conditions. In a proof-of-concept study, we delivered NIR-II photothermal agents and heat shock protein inhibitors for tumor-specific mild photothermal therapy. Compared to traditional photothermal therapy (PTT), this approach utilizes NIR-II PTT agents to achieve greater tissue penetration while downregulating heat shock proteins in tumor cells, resulting in precise thermal ablation at lower temperatures. In addition, the adSNAs are straightforward to synthesize and scalable for large-scale production, offering significant potential to advance the development of clinical targeted drugs.
48
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13
The entry of nanoparticles into solid tumours
Shrey Sindhwani, Abdullah M. Syed, Jessica Ngai et al. · Nature Materials · 2020 · 1.6K citations
Pharmacy, Cancer Biology, Oncology +12
Photothermally Enhanced Photodynamic Therapy Delivered by Nano-Graphene Oxide
Bo Tian, Chao Wang, Shuai Zhang et al. · ACS Nano · 2011 · 1.1K citations